Literature DB >> 27408403

Dasatinib and Dysfunction of Platelets.

Kamal Kant Sahu1, Uday Yanamandra1, Vikrant Bhar1, Deba Prasad Dhibar1, Subhash Chander Varma1, Pankaj Malhotra1.   

Abstract

Entities:  

Year:  2016        PMID： 27408403      PMCID： PMC4925558          DOI： 10.1007/s12288-016-0659-x

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN： 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  10 in total

Review 1.  Dietary manipulation of platelet function.

Authors:  E M Bachmair; L M Ostertag; X Zhang; B de Roos
Journal:  Pharmacol Ther       Date:  2014-05-21       Impact factor: 12.310

2.  Spontaneous subdural hematoma in a patient with Philadelphia chromosome-positive acute lymphoblastic leukemia with normal platelet count after dasatinib treatment.

Authors:  Moaath K Mustafa Ali; Marwa M Sabha; Kamal H Al-Rabi
Journal:  Platelets       Date:  2014-07-15       Impact factor: 3.862

3.  Gastrointestinal bleeding in a chronic myeloid leukaemia patient precipitated by dasatinib-induced platelet dysfunction: Case report.

Authors:  Louise Kostos; Kate Burbury; Gaurav Srivastava; H Miles Prince
Journal:  Platelets       Date:  2015-06-01       Impact factor: 3.862

4.  [Effect of low-dose dasatinib in an elderly patient with chronic myelogenous leukemia (CML)].

Authors:  Yuri Takagi; Yasuo Aota; Akihiko Gotoh; Michio Sakurai
Journal:  Gan To Kagaku Ryoho       Date:  2010-11

5.  [Intestinal bleeding in patients with chronic myelogenous leukemia treated with tyrosine kinase inhibitors].

Authors:  Makoto Saito; Koh Izumiyama; Akio Mori; Tatsuro Irie; Masanori Tanaka; Masanobu Morioka; Akiyoshi Saga; Manabu Musashi; Takashi Kato; Takashi Meguro; Mishie Tanino
Journal:  Rinsho Ketsueki       Date:  2014-01

6.  Tyrosine kinase inhibitor-induced platelet dysfunction in patients with chronic myeloid leukemia.

Authors:  Alfonso Quintás-Cardama; Xin Han; Hagop Kantarjian; Jorge Cortes
Journal:  Blood       Date:  2009-05-04       Impact factor: 22.113

7.  The effects of aspirin and fish oil consumption on lysophosphatidylcholines and lysophosphatidic acids and their correlates with platelet aggregation in adults with diabetes mellitus.

Authors:  Amir Abdolahi; Steve N Georas; J Thomas Brenna; Xueya Cai; Kelly Thevenet-Morrison; Richard P Phipps; Peter Lawrence; Shaker A Mousa; Robert C Block
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2013-12-18       Impact factor: 4.006

Review 8.  Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib.

Authors:  Amina Haouala; Nicolas Widmer; Michel A Duchosal; Michael Montemurro; Thierry Buclin; Laurent A Decosterd
Journal:  Blood       Date:  2010-09-01       Impact factor: 22.113

9.  Real-life comparison of severe vascular events and other non-hematological complications in patients with chronic myeloid leukemia undergoing second-line nilotinib or dasatinib treatment.

Authors:  Joanna Gora-Tybor; Ewa Medras; Malgorzata Calbecka; Agnieszka Kolkowska-Leśniak; Edyta Ponikowska-Szyba; Tadeusz Robak; Krzysztof Jamroziak
Journal:  Leuk Lymphoma       Date:  2015-03-05

Review 10.  Platelet function tests: a review of progresses in clinical application.

Authors:  Jae-Lim Choi; Shuhua Li; Jin-Yeong Han
Journal:  Biomed Res Int       Date:  2014-05-08       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.